Medicines suspended supply and manufacturing due to various reasons

Published: 2017-09-27 15:56:47

Updated: 2017-09-27 15:56:47

There are an increasing number of medicines going out of stock or be suspended manufacturing for various reasons.

Alvogen Korea is expected to suspend manufacturing of ‘Colonyte Powd’ and ‘Colonyte Powd 2L’ due to its supply suspension of active pharmaceutical ingredients. They are expected to run out of stock on March 2018 for Colonyte Powd and on June 2018 for Colonyte Powd 2L.

Abbott Korea...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.